JHC
GSK icon

JFB Holdings Corp’s GSK GSK Stock Holding History

JFB Holdings Corp’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$113M Sell
2,099,026
-4,284
-0.2% -$235K 3.61% 12
2016
Q2 		$114M Buy
2,103,310
+170,854
+9% +$9M 3.55% 11
2016
Q1 		$98M Buy
1,932,456
+25,208
+1% +$1.26M 2.91% 18
2015
Q4 		$96.2M Buy
1,907,248
+640,503
+51% +$32.6M 2.87% 20
2015
Q3 		$60.9M Sell
1,266,745
-56,617
-4% -$2.95M 1.83% 28
2015
Q2 		$68.9M Buy
1,323,362
+36,160
+3% +$2.04M 1.89% 30
2015
Q1 		$74.3M Buy
1,287,202
+140,424
+12% +$8.05M 1.92% 31
2014
Q4 		$61.3M Sell
1,146,778
-26,339
-2% -$1.47M 1.63% 33
2014
Q3 		$67.4M Buy
1,173,117
+59,568
+5% +$3.65M 1.88% 27
2014
Q2 		$74.4M Buy
1,113,549
+145,801
+15% +$9.87M 2.02% 27
2014
Q1 		$64.6M Buy
967,748
+111,948
+13% +$7.57M 2.03% 26
2013
Q4 		$57.1M Buy
855,800
+5,469
+0.6% +$355K 2.08% 27
2013
Q3 		$53.3M Buy
850,331
+44,379
+6% +$2.86M 2.1% 28
2013
Q2 		$50.3M Buy
+805,952
New +$51.2M 2.06% 29

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

JFB Holdings Corp's GSK Position: Q3 2016 in Review

JFB Holdings Corp reduced its GSK (GSK) stake by 0.2% in Q3 2016, selling an estimated $235K and leaving 2,099,026 shares worth $113M. The position accounts for 3.61% of the portfolio, ranked #12.

JFB Holdings Corp first reported a position in GSK in Q2 2013 and has held it in 14 quarters since. The position peaked at $114M in Q2 2016. 740 funds tracked by Wall St. Rank hold GSK as of Q3 2016.

  • JFB Holdings Corp held 2,099,026 shares of GSK worth $113M as of Q3 2016.
  • JFB Holdings Corp sold 4,284 GSK shares in Q3 2016, an estimated $235K.
  • GSK made up 3.61% of JFB Holdings Corp's portfolio in Q3 2016, its #12 holding.
  • JFB Holdings Corp first reported a position in GSK in Q2 2013 and has held it in 14 quarters since.
  • JFB Holdings Corp's GSK position peaked at $114M in Q2 2016.
  • 740 funds tracked by Wall St. Rank held GSK as of Q3 2016.

Based on JFB Holdings Corp's 13F filing for Q3 2016, filed 31 Oct 2016.